Partial-edentulism

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
1
Split-thickness groupPhase 41 trial
Active Trials
NCT05538715Unknown44Est. Sep 2024

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Geistlich PharmaSplit-thickness group

Clinical Trials (1)

Total enrollment: 44 patients across 1 trials

NCT05538715Geistlich PharmaSplit-thickness group

Reconstruction of Localized Alveolar Ridge Defects

Start: Nov 2019Est. completion: Sep 202444 patients
Phase 4Unknown

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space